MDM2/MDMX Other Immune Checkpoint Inhibitors Immunotherapy CD Protein Inhibitors Chemotherapy Epigenetics Wnt Signaling Inhibitors | Solid Tumor | Liposarcoma | Biliary Tract Cancer | Cholangiocarcinoma | Ampulla of Vater Carcinoma | Sarcoma | Hormone Receptor Positive Breast Cancer | Glioblastoma | Mucosal Melanoma | Gastric Adenocarcinoma | Diffuse Large B Cell Lymphoma | Melanoma | Soft Tissue Sarcoma | Triple Negative Breast Cancer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BI 907828 | ||||||||||||||
RAIN-32 | ||||||||||||||
APG-115 | ||||||||||||||
BI 907828 + BI 754091 | ||||||||||||||
pembrolizumab | ||||||||||||||
nivolumab + ipilimumab | ||||||||||||||
nivolumab | ||||||||||||||
ipilimumab | ||||||||||||||
eribulin mesylate | ||||||||||||||
Immunotherapy | ||||||||||||||
R-CHOP |